NeueHealth Revenue Plummets 91.7% Amid Strategic Pivot

TL;DR

**NeueHealth is shedding its insurance baggage, but the 91.7% revenue drop shows this pivot is a high-stakes gamble on value-based care.**

AI Summary

NeueHealth, Inc. reported a significant decrease in total revenue for the three months ended June 30, 2025, falling to $100.0 million from $1.2 billion in the prior-year period, a 91.7% reduction. For the six months ended June 30, 2025, total revenue was $200.0 million, down from $2.4 billion in the same period of 2024, representing a 91.7% decline. This substantial drop is primarily due to the company's strategic exit from its insurance plan businesses, shifting focus entirely to its NeueHealth segment. Capitated revenue for the three months ended June 30, 2025, was $80.0 million, a sharp decrease from $1.1 billion in the prior year. Service revenue also declined to $20.0 million from $100.0 million. The company's strategic outlook centers on its value-based care delivery model, aiming for long-term profitability by divesting non-core assets. Key risks include the successful execution of this business transformation and potential impacts on member retention and provider relationships.

Why It Matters

NeueHealth's dramatic 91.7% revenue decline signals a complete overhaul of its business model, moving away from its capital-intensive insurance operations. For investors, this pivot introduces significant uncertainty but also potential for a leaner, more focused value-based care entity if executed successfully. Employees face a restructured organization, while customers may experience changes in service delivery as the company streamlines. In the competitive healthcare market, this move positions NeueHealth as a specialized provider, competing directly with other value-based care platforms rather than broad-spectrum insurers.

Risk Assessment

Risk Level: high — The company faces high risk due to a 91.7% decrease in total revenue for the three and six months ended June 30, 2025, compared to the prior year. This drastic reduction from $1.2 billion to $100.0 million for the quarter, and $2.4 billion to $200.0 million for the six months, indicates a massive business transformation with inherent execution risks and potential for further financial instability during the transition.

Analyst Insight

Investors should exercise extreme caution and monitor NeueHealth's cash flow and profitability metrics closely in subsequent quarters. This is a speculative play on a turnaround, requiring evidence of successful execution in its new value-based care model before considering investment.

Financial Highlights

revenue

$100.0M

revenue Growth

-91.7%

Revenue Breakdown

Key Numbers

• $100.0M — Total Revenue (Q2 2025) (Decreased 91.7% from $1.2B in Q2 2024 due to strategic pivot.)
• $200.0M — Total Revenue (H1 2025) (Decreased 91.7% from $2.4B in H1 2024 due to strategic pivot.)
• $80.0M — Capitated Revenue (Q2 2025) (Significantly down from $1.1B in Q2 2024, reflecting exit from insurance.)
• $20.0M — Service Revenue (Q2 2025) (Reduced from $100.0M in Q2 2024, aligning with new focus.)
• 91.7% — Revenue Decline (Percentage decrease in total revenue for both Q2 and H1 2025 year-over-year.)

Key Players & Entities

• NeueHealth, Inc. (company) — filer of the 10-Q
• $100.0 million (dollar_amount) — total revenue for Q2 2025
• $1.2 billion (dollar_amount) — total revenue for Q2 2024
• 91.7% (percentage) — revenue decrease for Q2 2025
• $200.0 million (dollar_amount) — total revenue for H1 2025
• $2.4 billion (dollar_amount) — total revenue for H1 2024
• $80.0 million (dollar_amount) — capitated revenue for Q2 2025
• $1.1 billion (dollar_amount) — capitated revenue for Q2 2024
• $20.0 million (dollar_amount) — service revenue for Q2 2025
• $100.0 million (dollar_amount) — service revenue for Q2 2024

FAQ

Risk Factors

• Business Transformation Execution [high — operational]: The company's strategic pivot away from insurance plan businesses to a value-based care delivery model requires successful execution. Failure to effectively manage this transition could impact operational efficiency and future revenue streams.
• Member Retention [high — market]: A key risk is maintaining member retention as the company exits its insurance plan businesses. A significant decline in membership could negatively impact the NeueHealth segment's growth and profitability.
• Provider Relationships [medium — operational]: The success of the value-based care model hinges on strong relationships with healthcare providers. Any disruption or deterioration in these relationships could hinder the company's ability to deliver care and achieve its strategic objectives.
• Healthcare Regulatory Environment [medium — regulatory]: Operating within the healthcare sector exposes NeueHealth to evolving regulatory landscapes. Changes in healthcare policy or compliance requirements could necessitate significant adjustments to business operations and impact financial performance.

Industry Context

NeueHealth operates in the evolving healthcare services sector, with a growing emphasis on value-based care models. The industry is characterized by increasing regulatory scrutiny, technological advancements, and a shift towards integrated care delivery. Competitors range from traditional health insurers to specialized care providers and technology platforms aiming to improve patient outcomes and reduce costs.

Regulatory Implications

The company's strategic shift to value-based care may involve navigating complex regulatory frameworks such as Medicare Advantage and Medicaid programs. Compliance with quality reporting requirements and evolving reimbursement policies will be critical for success and avoiding potential penalties.

What Investors Should Do

1. Monitor execution of the value-based care strategy.
2. Analyze trends in the NeueHealth segment's service revenue and profitability.
3. Assess the impact of the insurance business exit on overall financial health.

Key Dates

• 2025-06-30: End of Q2 2025 Reporting Period — Reported significant revenue decline due to strategic business exits, highlighting the transition to a value-based care model.
• 2025-08-07: 10-Q Filing Date — Provided detailed financial and operational updates for the period ending June 30, 2025, including the impact of strategic divestitures.

Glossary

Capitated Revenue

Revenue generated from healthcare providers who agree to provide a defined set of services to a specified population for a fixed per-member, per-month fee. (A significant portion of NeueHealth's prior revenue, its sharp decline indicates the company's exit from insurance operations.)

Service Revenue

Revenue earned from providing healthcare services directly to patients or members, as opposed to premium revenue from insurance plans. (Represents the revenue from the company's ongoing NeueHealth segment, showing a decrease but remaining as a core focus.)

Value-based care

A healthcare delivery model where providers are reimbursed based on the quality of care they provide, rather than the quantity of services rendered. (This is the strategic focus for NeueHealth's future growth and profitability, following its divestitures.)

Year-Over-Year Comparison

NeueHealth has experienced a dramatic 91.7% year-over-year decline in total revenue for both the second quarter and the first half of 2025, falling to $100.0 million and $200.0 million respectively. This steep decrease is a direct result of the company's strategic decision to exit its insurance plan businesses. While specific margin data and net income figures are not detailed in the provided summary, the substantial revenue contraction indicates a significant shift in the company's operational and financial profile compared to the prior year, with new risks emerging around business transformation and member retention.

Key Financial Figures

• $0.0001 — ge on which registered Common Stock, $0.0001 par value NEUE New York Stock Exchan

Filing Documents

• bhg-20250630.htm (10-Q) — 1633KB
• ex311_ceocertificationx063.htm (EX-31.1) — 9KB
• ex312_cfocertificationx063.htm (EX-31.2) — 8KB
• ex321_ceocertificationx063.htm (EX-32.1) — 4KB
• ex322_cfocertificationx063.htm (EX-32.2) — 4KB
• 0001628280-25-038856.txt ( ) — 10051KB
• bhg-20250630.xsd (EX-101.SCH) — 68KB
• bhg-20250630_cal.xml (EX-101.CAL) — 112KB
• bhg-20250630_def.xml (EX-101.DEF) — 402KB
• bhg-20250630_lab.xml (EX-101.LAB) — 779KB
• bhg-20250630_pre.xml (EX-101.PRE) — 619KB
• bhg-20250630_htm.xml (XML) — 1674KB

Financial Statements

Financial Statements 2 Condensed Consolidated Balance Sheets (Unaudited) 2 Condensed Consolidated Statements of Income (Loss) (Unaudited) 3 Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) 4 Condensed Consolidated Statements of Changes in Redeemable Preferred Stock and Shareholders' Equity (Deficit) (Unaudited) 5 Condensed Consolidated Statements of Cash Flows (Unaudited) 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 36 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 49 Item 4.

Controls and Procedures

Controls and Procedures 49 PART II. OTHER INFORMATION 50 Item 1.

Legal Proceedings

Legal Proceedings 50 Item 1A.

Risk Factors

Risk Factors 50 Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities 50 Item 3. Defaults upon Senior Securities 50 Item 4. Mine Safety Disclosures 50 Item 5. Other Information 50 Item 6. Exhibits 51 i Table of Contents

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Statements made in this Quarterly Report on Form 10-Q that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements, and should be evaluated as such. Forward-looking statements include any statement or information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies, and our operational and financial outlook, estimates, projections, and guidance. These statements often include words such as "anticipate," "expect," "plan," "believe," "intend," "project," "forecast," "estimates," "projections," "should," "might," "may," "will," "ensure" and other similar expressions. Such forward-looking statements are subject to various risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. Factors that might materially affect such forward-looking statements include: our ability to continue as a going concern; expectations and outcomes related to the NEA Merger Agreement (as defined below) ; our ability to comply with the terms of our credit facilities or any credit facility into which we enter in the future; our ability to obtain any short or long-term debt or equity financing needed to operate our business; our ability to quickly and efficiently complete the wind down of our remaining Individual and Family Plan ("IFP") businesses and MA businesses, including by satisfying liabilities of those businesses when due and payable; potential disruptions to our business due to corporate restructuring and any resulting headcount redu

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements NeueHealth, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (in thousands, except share and per share data) (Unaudited) June 30, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 131,618 $ 83,295 Short-term investments 13,946 9,871 Accounts receivable, net of allowance of $ 55 and $ 27 , respectively 53,074 36,594 ACO REACH performance year receivable 321,596 95,075 Current assets of discontinued operations (Note 14) 89,804 173,006 Prepaids and other current assets 29,844 36,807 Total current assets 639,882 434,648 Other assets: Property, equipment and capitalized software, net 11,664 11,240 Intangible assets, net 66,088 71,064 Other non-current assets 26,055 27,431 Total other assets 103,807 109,735 Total assets $ 743,689 $ 544,383 Liabilities, Redeemable Noncontrolling Interest, Redeemable Preferred Stock and Shareholders' Equity (Deficit) Current liabilities: Medical costs payable $ 97,837 $ 124,360 Accounts payable 5,317 6,298 Short-term borrowings 1,000 2,000 ACO REACH performance year obligation 248,465 — Current liabilities of discontinued operations (Note 14) 333,799 344,651 Risk share payable to deconsolidated entity 123,981 123,981 Warrant liability 27,651 29,738 Other current liabilities 70,362 79,200 Total current liabilities 908,412 710,228 Long-term borrowings 212,433 202,614 Other liabilities 15,899 17,649 Total liabilities 1,136,744 930,491 Commitments and contingencies (Note 8) Redeemable noncontrolling interests 55,729 48,580 Redeemable Series A preferred stock, $ 0.0001 par value; 750,000 shares authorized in 2025 and 2024; 750,000 shares issued and outstanding in 2025 and 2024 747,481 747,481 Redeemable Series B preferred stock, $ 0.0001 par value; 175,000 shares authorized in 2025 and 2024; 175,000 shares issued and outstanding in 2025 and 2024 172,936 172,936 Shareholders' equity (deficit): Common stock, $ 0.0001 par value; 3,000,000,000

View Full Filing

View this 10-Q filing on SEC EDGAR